Back to NORGES BANK NORGES BANK

PTGXPTGX
5 quarters

Position history for NORGES BANKNORGES BANK's holdings in PROTAGONIST THERAPEUTICS INC

NORGES BANK previously held 0 shares of PTGX (PROTAGONIST THERAPEUTICS INC), worth $0 as of 2023-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$218,000

Total Shares Change

-11,160

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2023-Q1
Latest
Exited
0
-100.0%
$00.0%$22.49
0
2022-Q4
New
148,700
-
$1.6M0.0%$10.91
35
2021-Q1
Exited
0
-100.0%
$00.0%$25.31
0
2020-Q4
Unchanged
11,160
0.0%
$225,0000.0%$19.99
0
2020-Q3
New
11,160
-
$218,0000.0%$20.25
32

Other major holders of PTGX: BlackRock, Inc., FARALLON CAPITAL MANAGEMENT, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used